Ibuprofen inhibits COX-1 enzymes through a specific molecular mechanism of action.
Evidence from pharmacological and crystallographic studies confirms that ibuprofen acts as a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes (such as COX-1) through specific molecular mechanisms involving active-site binding and electrostatic interactions.
The claim specifies that ibuprofen inhibits COX-1 enzymes through a specific molecular mechanism. Papers [6] and [11] discuss the molecular basis of NSAID action and explicitly analyze ibuprofen's structural binding and interactions with cyclooxygenase enzymes. The evidence supports the claim.
Praveen P. N. Rao, Edward E. Knaus. Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond. 2008. https://doi.org/10.18433/j3t886
This review details the mechanism of action of nonsteroidal anti-inflammatory drugs at the molecular level, specifically discussing cyclooxygenase (COX) inhibition and the structural basis for COX-1 and COX-2 inhibition by classic NSAIDs like ibuprofen.
See more details
S. Pawlędzio, M. Ziemniak, X. Wang, K. Woźniak, M. Malińska. Understanding the selectivity of nonsteroidal anti-inflammatory drugs for cyclooxygenases using quantum crystallography and electrostatic interaction energy. 2025. https://doi.org/10.1107/S2052252525000053
This study employs quantum crystallography to analyze binding energy and electrostatic interactions, explicitly elucidating the molecular mechanisms and selectivity of NSAIDs, including ibuprofen, for cyclooxygenase enzymes.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt